Malindang, Lyne Z.
HRN: 17-20-02 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/27/2023
CEFUROXIME 1.5GM (VIAL)
10/27/2023
10/27/2023
IV
1.5grams
On Call To OR
For STAT Pelvic Lap
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes